Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2303
mi
from 91732
Weston, FL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2303
mi
from 91732
Weston, FL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1422
mi
from 91732
Des Moines, IA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1955
mi
from 91732
Bingham Farms, MI
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1955
mi
from 91732
Bingham Farms, MI
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1951
mi
from 91732
West Bloomfield, MI
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1951
mi
from 91732
West Bloomfield, MI
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1505
mi
from 91732
Golden Valley, MN
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1505
mi
from 91732
Golden Valley, MN
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2437
mi
from 91732
Albany, NY
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2437
mi
from 91732
Albany, NY
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2469
mi
from 91732
Commack, NY
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2469
mi
from 91732
Commack, NY
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1938
mi
from 91732
Toledo, OH
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1938
mi
from 91732
Toledo, OH
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1253
mi
from 91732
Tulsa, OK
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1253
mi
from 91732
Tulsa, OK
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1357
mi
from 91732
Houston, TX
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1357
mi
from 91732
Houston, TX
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
967
mi
from 91732
Kirkland, WA
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
967
mi
from 91732
Kirkland, WA
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
1363
mi
from 91732
Edmonton,
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
1363
mi
from 91732
Edmonton,
Click here to add this to my saved trials
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
25
mi
from 91732
Fountain Valley, CA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
25
mi
from 91732
Fountain Valley, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
320
mi
from 91732
Sunnyvale, CA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
320
mi
from 91732
Sunnyvale, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2180
mi
from 91732
Port Charlotte, FL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2180
mi
from 91732
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2305
mi
from 91732
Sunrise, FL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2305
mi
from 91732
Sunrise, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2296
mi
from 91732
Elkridge, MD
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2296
mi
from 91732
Elkridge, MD
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1951
mi
from 91732
West Bloomfield, MI
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1951
mi
from 91732
West Bloomfield, MI
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2152
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1253
mi
from 91732
Tulsa, OK
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1253
mi
from 91732
Tulsa, OK
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2134
mi
from 91732
Roanoke, VA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2134
mi
from 91732
Roanoke, VA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
967
mi
from 91732
Kirkland, WA
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
967
mi
from 91732
Kirkland, WA
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
2122
mi
from 91732
Morgantown, WV
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
2122
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated:  1/9/2018
6001
mi
from 91732
Innsbruck,
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
ADS-5102 (Amantadine HCl) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia (EASE LID 3 Study)
Status: Enrolling
Updated: 1/9/2018
6001
mi
from 91732
Innsbruck,
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center, Dignity Health
343
mi
from 91732
Phoenix, AZ
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center, Dignity Health
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials